GlassScriptPhysician profile
Cliff Burmeister
NPI 1851783831
$4,124.72
in general payments reported to CMS, 2019-2025
27 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $352 · 2021: $242 · 2022: $1,448 · 2023: $226 · 2024: $794 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038 · Education: $286 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.22 |
| Education | $286.05 |
| Travel and Lodging | $258.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,318.00 | 2021-2022 | |
| Biocomposites INC | $522.23 | 2019-2025 | Stimulan |
| Curonix LLC | $304.69 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Linvatec Corporation | $295.56 | 2024 | Biobrace 23mm |
| Paratek Pharmaceuticals, INC. | $272.73 | 2022-2025 | Nuzyra |
| Integra Lifesciences Corporation | $205.17 | 2019 | |
| Stryker Corporation | $134.47 | 2019 | |
| Organogenesis INC. | $132.82 | 2020-2025 | Puraply, Puraply Wound Matrix |
| Kerecis Limited | $119.09 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Mindray Ds USA, INC. | $94.64 | 2022 | |
| Smith+Nephew, INC. | $93.89 | 2019-2025 | Collagenase Santyl |
| Djo, LLC | $75.46 | 2021-2025 | Cmf |
| Treace Medical Concepts, INC. | $67.29 | 2024 | |
| Solventum Corporation | $61.99 | 2024-2025 | 3m Cavilon, Activ.A.C., Promogran Prisma |
| Horizon Therapeutics Plc | $56.25 | 2021-2023 | Krystexxa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $56.14 | 2021-2024 | Intellis Adaptivestim |
| Triad Life Sciences INC. | $42.05 | 2022 | |
| Orthofix Medical, INC. | $41.02 | 2022-2023 | Physio-Stim |
| Wright Medical Technology, INC. | $39.69 | 2019 | |
| Depuy Synthes Sales INC. | $39.36 | 2021 | |
| Nevro Corp. | $37.12 | 2019-2023 | Senza |
| Molnlycke Health Care US, LLC | $31.50 | 2025 | Mepilex Border Flex, Mepilex Border, Exufiber Ag+ |
| Reprise Biomedical, INC. | $27.95 | 2024 | Miro3d |
| Bioventus LLC | $16.17 | 2019 | |
| Kuros Biosciences USA, INC | $14.83 | 2025 | Magnetos |
| Arthrosurface Incorporated | $13.72 | 2019 | |
| Melinta Therapeutics, LLC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cliff Burmeister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.